Pharmacy Consulting

Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.

News & Events

Dave Schuetz and Fred Hamlin Attending NCPDP’s February Work Group Meetings

PHSI Director of Business Development Fred Hamlin and PHSI Consultant Dave Schuetz will be attending the NCPDP Joint Technical Work Group Meetings February 6 and 7, 2019 at the Hyatt Regency on the Riverwalk in San Antonio, TX.  The Work Group Meetings provide a venue for NCPDP members and industry stakeholders to come together to address Read More →

Melissa Krause to Attend PPA 2019 Mid-Year Conference

PHSI Consultant Pharmacist Melissa Krause will be attending the Pennsylvania Pharmacists Association 2019 Mid-Year Conference on January 25-27 in Gettysburg, Pennsylvania.  To schedule a meeting with Melissa during the conference, please click here to contact PHSI.  Student pharmacists interested in a part-time internship for 2019-2020 or APPE rotation at PHSI are welcome to schedule time Read More →

FDA Proposed Framework for Digital Therapeutics: “Prescription Drug-Use-Related Software”

By now you may have seen FDA’s Federal Register Notice,  “Prescription Drug-Use-Related Software”, which establishes a docket seeking public input on digital therapeutics.  The proposed framework is for discussion purposes only; it is not a draft guidance but a way for FDA to seek input from stakeholders.  The document gives insight into how FDA may Read More →

Latest from the Blog

Impact of the Opioid Crisis Response Act

On October 24, 2018, President Trump signed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities, or the SUPPORT for Patients and Communities Act. This bill, referred to as the Opioid Crisis Response Act, will have direct impacts on an array of areas within pharmacy and healthcare settings including The Read More →

A Primer on Partial GPIs and FDB Supersets

Drug compendia are excellent resources that are used either directly or indirectly by almost all stakeholders in the pharmaceutical industry. Two of the leading drug compendia providers are Wolters Kluwer (Medi-Span) and First Databank (FDB). Pharmaceutically equivalent products are those that share the same active ingredient(s), strength/concentration, dosage form, and route of administration. Both compendia Read More →

A Review of the Express Script (ESI) Flex Formulary

Overview: Last month, Express Scripts announced that they will be introducing a new Flex Formulary, which is expected to mirror the Express Scripts National Preferred Formulary (NPF) as a starting point.  The new Flex formulary will allow ESI to easily add new, lower cost products in the middle of a plan year as they are Read More →